Logo for Sprint Bioscience

Sprint Bioscience Investor Relations Material

Latest events

Logo for Sprint Bioscience

Q3 2023

25 Oct, 2023
Logo for Sprint Bioscience

Q2 2023

24 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
Sprint Bioscience AB engages in developing VPS34, a drug candidate for the treatment of various types of cancer; and PETRA01, a drug candidate for the treatment of cancer. The company also focuses on research of products for the treatment of tumor metabolism and type 2 diabetes. Sprint Bioscience AB was founded in 2009 and is based in Huddinge, Sweden.